Direct Corporate Access

BTIG to Host Inaugural China Biotech Day on Wednesday, June 1, 2022

Retrieved on: 
Thursday, May 26, 2022

BTIG announced today that it will hold an inaugural China Biotech Day, on Wednesday, June 1, 2022.

Key Points: 
  • BTIG announced today that it will hold an inaugural China Biotech Day, on Wednesday, June 1, 2022.
  • The conference will be hosted by:
    Industry-leading biotechnology companies with operations in China will be participating in the firms conference.
  • The Chinese biotech sector is primed for growth due to accelerating drug development entering the global marketplace, said Justin Zelin, BTIG Biotechnology Analyst.
  • Panel discussion topics will include state of China biotech investments, cross border collaborations, Chinas healthcare market and reimbursement, and accounting standards.

Identity and Access Management & Cybersecurity Provider BIO-key to Participate in H.C. Wainwright Global Investment Conference, CEO Presentation Available Starting Tue., May 24

Retrieved on: 
Friday, May 20, 2022

The companys presentation will be available on demand beginning Tuesday, May 24th at 7am ET.

Key Points: 
  • The companys presentation will be available on demand beginning Tuesday, May 24th at 7am ET.
  • BIO-keys CEO Mike DePasquale will be available for virtual investor meetings on Wednesday, May 25th and Thursday, May 26th.
  • H.C. Wainwright & Co., LLC is a full-service investment bank providing Investment Banking, Equity Research, Sales & Trading, Corporate Access and Strategic Advisory services.
  • H.C. Wainwrights Global Investment Conference will feature company presentations and meetings with leading technology, media, telecommunications and other growth companies over three days.

Jasper Commerce Inc. Virtually Closes the Market

Retrieved on: 
Thursday, March 31, 2022

TORONTO, March 31, 2022 /CNW/ - Jon Marsella, Founder and Chief Executive Officer, Jasper Commerce Inc. ("Company") (TSXV: JPIM) and his team joined Omar Khafagy, Manager, Corporate Access, TSX Company Services, Toronto Stock Exchange, to celebrate the Company's new listing on TSX Venture Exchange and close the market.

Key Points: 
  • TORONTO, March 31, 2022 /CNW/ - Jon Marsella, Founder and Chief Executive Officer, Jasper Commerce Inc. ("Company") (TSXV: JPIM) and his team joined Omar Khafagy, Manager, Corporate Access, TSX Company Services, Toronto Stock Exchange, to celebrate the Company's new listing on TSX Venture Exchange and close the market.
  • Jasper offers a Product Information Management solution that has the objective of empowering eCommerce merchants to manage and merchandise their products from a single source of truth, facilitating them to sell more, sell faster and work smarter.
  • Jasper's PIM is accessible from anywhere via a web-browser and is intended to simplify the process by which online merchants import product data into the PIM.
  • Jasper's PIM also allows for automatic syncing to popular eCommerce storefronts, marketplaces, or other connected channels, whenever new products are added to the PIM.

Nextech AR Solutions to Participate in the Lytham Partners Spring 2022 Investor Conference

Retrieved on: 
Thursday, March 31, 2022

Nextech AR Solutions is the engine accelerating the growth of the Metaverse.

Key Points: 
  • Nextech AR Solutions is the engine accelerating the growth of the Metaverse.
  • With a full suite of end-to-end AR solutions in 3D Commerce, Education, Events, and Industrial Manufacturing, Nextech AR is in a unique position to meet the needs of the worlds biggest brands and all Metaverse contributors.
  • Nextech funds the development of its AR and Metaverse growth initiatives through its e-Commerce platforms, which currently generate most of its revenue.
  • Nextech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

IBN (InvestorBrandNetwork) and InvestorWire Re-Engaged to Heighten the Visibility of the Upcoming Roth Investor Conference

Retrieved on: 
Monday, February 7, 2022

The two-day investment conference will bring together executives from hundreds of public and private companies as well as thousands of attendees.

Key Points: 
  • The two-day investment conference will bring together executives from hundreds of public and private companies as well as thousands of attendees.
  • For the 12th year in a row, IBN will expand the distribution of content generated for the event.
  • We are pleased to be continuing our ongoing association with IBN, stated Isabel Mattson-Pain, Roths Director of Marketing & Corporate Access.
  • Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://IBN.fm/Disclaimer

BTIG Franchise Sales Adds FinTech Strategy and Sales Specialist Michael Turner

Retrieved on: 
Tuesday, January 25, 2022

BTIG announced today that Michael Turner has joined the firms Franchise Sales division as a Managing Director and FinTech Strategy and Sales Specialist.

Key Points: 
  • BTIG announced today that Michael Turner has joined the firms Franchise Sales division as a Managing Director and FinTech Strategy and Sales Specialist.
  • In his new role with the firm, he will report to Dan Wychulis, Managing Director and Head of BTIG U.S. Strategy and Franchise Sales.
  • He joins an established team focused on the evolution of fintech and banking, traditional finance and the housing ecosystem including, BTIG Mortgage and Specialty Finance Sales Specialist Gabe Poggi, Managing Director, and BTIG Digital Assets Strategy and Sales Specialists Michael Kaye, Managing Director, and David Arnold, Director.
  • Stephen Terry, Managing Director and Head of BTIG FinTech Investment Banking, is leading the firms advisory practice for fintech corporate clients.

CICC Tops Institutional Investor 2021 All-China Sales and Research Team for the 10th Consecutive Year and Ranks First China's Corporate Access Provider

Retrieved on: 
Tuesday, January 18, 2022

BEIJING, Jan. 18, 2022 /PRNewswire/ --China International Capital Corporation Limited tops the 2021 Institutional Investor rankings in All-China Sales, Research Team and Corporate Access Provider.

Key Points: 
  • BEIJING, Jan. 18, 2022 /PRNewswire/ --China International Capital Corporation Limited tops the 2021 Institutional Investor rankings in All-China Sales, Research Team and Corporate Access Provider.
  • This marks the 10th consecutive year for CICC to top overall sales provider and research team (2012-2021), in a survey that collects the opinions ofmore than2,800 domestic and internationalinvestment professionals at some 950institutions.
  • "Sales services in China, especially at CICC, have become increasingly sophisticated in the past two years to cope with ongoing pandemic impacts," Huang Haizhou, Head of Equities at CICC said.
  • For more information, please refer to the Institutional Investor articles:
    For more than 30 years, Institutional Investor has recognized people and firms in the financial services industry for excellence.

TALOS ENERGY PRESIDENT & CEO TIMOTHY S. DUNCAN TO PARTICIPATE IN A FIRESIDE CHAT WITH LEO MARIANI, EQUITY RESEARCH ANALYST FOR KEYBANC CAPITAL MARKETS INC.

Retrieved on: 
Tuesday, January 4, 2022

HOUSTON, Jan. 4, 2022 /PRNewswire/ --Talos Energy Inc. (NYSE: TALO)("Talos" or the "Company") today announced that Talos's President & CEO Timothy S. Duncan will participate in a detailed, one-on-one fireside chat with Leo Mariani, CFA, who covers the Company on behalf of KeyBanc Capital Markets Inc.

Key Points: 
  • HOUSTON, Jan. 4, 2022 /PRNewswire/ --Talos Energy Inc. (NYSE: TALO)("Talos" or the "Company") today announced that Talos's President & CEO Timothy S. Duncan will participate in a detailed, one-on-one fireside chat with Leo Mariani, CFA, who covers the Company on behalf of KeyBanc Capital Markets Inc.
  • The fireside chat will include a comprehensive discussion on Talos's carbon capture and traditional energy businesses, M&A and much more.
  • The entire session is expected to run for approximately one hour.
  • For registration and further details, please contact Lisa Setow, KeyBanc Capital Markets Assistant Vice President for Corporate Access, at [email protected] .

NOXXON to Participate in Banking and Investor Conferences in January and February 2022

Retrieved on: 
Wednesday, December 15, 2021

NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announces that Aram Mangasarian, CEO of NOXXON, and Bryan Jennings, CFO of NOXXON, will participate and be available for meetings at several banking and investor conferences in early 2022.

Key Points: 
  • NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announces that Aram Mangasarian, CEO of NOXXON, and Bryan Jennings, CFO of NOXXON, will participate and be available for meetings at several banking and investor conferences in early 2022.
  • BIOCONNECT hosted by H.C. Wainwright aims to connect life sciences companies with a diverse roster of investors.
  • NOXXONs corporate video presentation will be available on demand from January 10 at 7:00 a.m.
  • The company cautions prospective investors not to rely on such forward-looking statements as certain prognoses of actual future events and developments.

Anixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference

Retrieved on: 
Thursday, December 16, 2021

Participation and presentation details are below:

Key Points: 
  • Participation and presentation details are below:
    LifeSci Partners Corporate Access Event:
    Dr. Amit Kumar, Chairman, President and Chief Executive Officer of Anixa Biosciences will present on a panel entitled, "Cancer Vaccines: Promises, PromisesHas Their Day Come?"
  • During the duration of the LifeSci Corporate Access Event, the Anixa Biosciences management team will be available for 1x1 meetings with interested investors.
  • Anixa Biosciences will present at the H.C. Wainwright BioConnect Conference and a recording of the presentation will be accessible beginning January 10th at 7:00 am ET.
  • You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.